Pnc Financial Services »

Arrivent Biopharma shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $148 8 18.50

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Erie Indty Cl A (ERIE)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw E (IWF)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Us Qtly Div Gr (DGRW)

View all positions for Pnc Financial Services

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
Infinitum Asset Management
Suvretta Capital Management
FMR
OrbiMed Advisors
BlackRock
Vanguard Group
Octagon Capital Advisors
Novo A/S
Sofinnova Ventures
General Catalyst Group Management
State Street Corporation
Geode Capital Management
Siren
Sc China Holding

View all funds holding Arrivent Biopharma